2,736 press releases indexed under healthcare.
The article outlines how evidence, medical records, and Pennsylvania fault laws affect personal injury claims after an accident. READING, Penn., July 6, 2026 /PRNewswire/ -- What steps should someone take after an accident to help protect their legal rights? Mark E. Zimmer, Family Law...
WALTHAM, Mass., July 06, 2026 (GLOBE NEWSWIRE) -- Xilio Therapeutics, Inc. (Nasdaq: XLO), a clinical-stage biotechnology company discovering and developing masked immuno-oncology therapies for people living with cancer, today announced that, effective July 1, 2026, the company granted non-qualified stock options to purchase 107,060 shares of its common stock to three new employees under Xilio Therapeutics’ 2022 Inducement Stock Incentive Plan.
ALISO VIEJO, Calif., July 06, 2026 (GLOBE NEWSWIRE) -- Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, and RxSight, Inc. (NASDAQ: RXST), an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, today announced a non-exclusive collaboration to jointly develop adjustable presbyopia-correcting intraocular lenses (PCIOLs).
PHILADELPHIA, July 06, 2026 (GLOBE NEWSWIRE) -- Context Therapeutics Inc. (“Context” or the “Company”) (Nasdaq: CNTX), a clinical-stage biopharmaceutical company advancing T cell engaging (“TCE”) bispecific antibodies for solid tumors, today announced that the Company was added to the small-cap Russell 2000 ® and the broad-market Russell 3000 ® Indexes, effective at the close of U.S. equity markets on June 26, 2026.
D.C. and Baltimore firsts bring "mini hip replacement" innovation to thumb arthritis care. COLUMBIA, Md., July 6, 2026 /PRNewswire/ -- MedStar Health hand surgeons in both D.C. and Baltimore became the first in their respective regions to perform a break-through treatment for patients...
(PR-inside.com) DOJ Says the Controlled Substances Act Protects Legitimate Scientific Research. MMJ Says the Government Should Start Treating It That Way. "The government cannot tell companies to spend years following the FDA's scientific pathway, then dismiss those same efforts as a 'pocketbook interest' when they seek equal treatment under the law. We didn't build a market-we built a medicine." stated Duane Boise, President & CEO, MMJ International Holdings WASHINGTON, DC / ACCESS Newswire / July 6, 2026 /MMJ International Holdings, Inc. (MMJIH), together with MMJ BioPharma Cultivation, Inc. and MMJ BioPharma Labs, Inc., today responded to the Department of Justice's recent filing before ..
DOJ Says the Controlled Substances Act Protects Legitimate Scientific Research. MMJ Says the Government Should Start Treating It That Way. "The government cannot tell companies to spend years following the FDA's scientific pathway, then dismiss those same efforts as a 'pocketbook interest' when they seek equal treatment under the law. We didn't build a market-we built a medicine." stated Duane Boise, President & CEO, MMJ International Holdings
LOS ANGELES, CA - July 6, 2026 ( NEWMEDIAWIRE ) - VERAXA Biotech (NASDAQ: VRXA) provided a corporate and pipeline update highlighting progress during the first half of 2026, including continued advancement of its proprietary BiTAC(R) platform and growing interest from potential pharmaceutical partners. The company said its pipeline now includes four BiTAC-based T-cell engager programs targeting solid tumors, two bispecific antibody-drug conjugate (“ADC”) programs and two non-BiTAC assets available for partnering. VERAXA said it plans to prioritize investment in its BiTAC portfolio while seeking to monetize selected non-BiTAC programs to help finance future development, with the goal of advancing lead BiTAC-TCE candidate VXA-102 to IND/CTA readiness by early 2028. Company executives also ci
House dust is a part of everyday life, yet few people fully understand what it contains or how it can impact human health. Far from being simple dirt, house dust is a complex mixture of materials originating from both indoor and outdoor environments. These may include soil particles, human skin cells, pet dander, textile fibers, pollen, mold spores, and microscopic organisms such as dust mites and their waste byproducts. - - For many individuals, exposure to house dust can trigger allergic... Read the full story at https://www.webwire.com/ViewPressRel.asp?aId=357231
Cosmos Health has now repurchased a total of 3,640,000 shares for approximately $700,000
Monday 6 July, 2026 Kentown Support is delighted to announce that it has won the Partnership Working Across Health and Social Care Award at the 2026 Palliative and End of Life Care Awards. This national recognition celebrates the collaborative approach at the heart of the Kentown programme model and acknowledges the impact of partnership working in delivering coordinated, family-centred care for seriously ill children and young people. The category recognises teams that demonstrate exceptional multi-level collaboration across the health and social care sectors, creating lasting and sustainable impact beyond individual organisations. While the judges recognised the Kentown programme model overall, they paid tribute to its Greater Manchester programme, commenting that it: “Delivers an except
The global Medical Equipment Maintenance Market size was valued at USD 41.9 billion in 2023 and is projected to grow from USD 55.4 billion in 2026 to [read full press release...]